Algorae Pharmaceuticals LVCLF Stock
Algorae Pharmaceuticals Price Chart
Algorae Pharmaceuticals LVCLF Financial and Trading Overview
| Algorae Pharmaceuticals stock price | 0.0069 USD |
| Previous Close | 0.0099 USD |
| Open | 0.00885 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0099 - 0.0099 USD |
| 52 Week Range | 0.0045 - 0.01 USD |
| Volume | 40K USD |
| Avg. Volume | 668 USD |
| Market Cap | 16.45M USD |
| Beta (5Y Monthly) | 0.776 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LVCLF Valuation Measures
| Enterprise Value | 12.08M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 391.4289 |
| Price/Book (mrq) | 4.95 |
| Enterprise Value/Revenue | 287.553 |
| Enterprise Value/EBITDA | -9.535 |
Trading Information
Algorae Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.776 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.0045 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.00772735 USD |
LVCLF Share Statistics
| Avg. Volume (3 month) | 668 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 1.66B |
| Float | 1.03B |
| Short Ratio | N/A |
| % Held by Insiders | 29.21% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2023 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | June 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -801.77% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.67% |
| Return on Equity (ttm) | -54.064% |
Income Statement
| Revenue (ttm) | 42.02K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 1133.60% |
| Gross Profit (ttm) | 42.02K USD |
| EBITDA | -1267052 USD |
| Net Income Avi to Common (ttm) | -2107658 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.11M USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.352 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1986291 USD |
| Levered Free Cash Flow (ttm) | -648551 USD |
Profile of Algorae Pharmaceuticals
| Country | United States |
| State | VIC |
| City | Melbourne |
| Address | Rialto South Tower |
| ZIP | 3000 |
| Phone | 61 2 9698 5414 |
| Website | https://www.algoraepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.
Q&A For Algorae Pharmaceuticals Stock
What is a current LVCLF stock price?
Algorae Pharmaceuticals LVCLF stock price today per share is 0.0069 USD.
How to purchase Algorae Pharmaceuticals stock?
You can buy LVCLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Algorae Pharmaceuticals?
The stock symbol or ticker of Algorae Pharmaceuticals is LVCLF.
Which industry does the Algorae Pharmaceuticals company belong to?
The Algorae Pharmaceuticals industry is Biotechnology.
How many shares does Algorae Pharmaceuticals have in circulation?
The max supply of Algorae Pharmaceuticals shares is 1.79B.
What is Algorae Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Algorae Pharmaceuticals PE Ratio is now.
What was Algorae Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Algorae Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Algorae Pharmaceuticals company belong to?
The Algorae Pharmaceuticals sector is Healthcare.